Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Kinya Koizumi"'
Autor:
Takashi Yamaguchi, Satoshi Ogiso, Hiroaki Hata, Sachiko Minamiguchi, Nobuyuki Tsuchiya, Toshio Yamato, Kinya Koizumi, Tetsushi Otani, Natsue Uehiro
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 43:202-207
Autor:
Hiroya Kuroyanagi, Masanori Fukushima, Satoshi Teramukai, Harue Tada, Takashi Yamaguchi, Hiroaki Hata, Koya Hida, Satoshi Nagayama, Kinya Koizumi, Yoshiharu Sakai
Publikováno v:
World Journal of Surgery. 33:1733-1740
Laparoscopic surgery is widely used for the treatment of colorectal cancer, but little is known about perioperative risk factors for complications. Clinical data were reviewed for 401 consecutive unselected colorectal cancer patients who underwent la
Autor:
Kinya Koizumi, Hiroaki Hata, Shingo Sakata, Hisashi Nishida, Yoshiharu Sakai, Toshiharu Tokuriki
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 62:2564-2569
症例は37歳女性.肝腫瘤精査のため受診, CT上肝右葉を占拠し著明に造影される腫瘍を認めた.入院後腫瘍の破裂による腹腔内出血をきたし,肝動脈塞栓術にて止血後,肝右葉切除術を施行した
Autor:
Shingo Sakata, Hiroya Kuroyanagi, Nobuyuki Tsuchiya, Ken Kameyama, Tetsushi Otani, Kinya Koizumi, Hisashi Nishida, Yoshiharu Sakai, Toshiharu Tokuriki
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 34:1596-1600
症例は67歳の男性, 腹部不快感を訴え, 1991年11月当院受診, 精査にて胃幽門前庭部に2型進行癌を指摘され, 1992年3月手術を施行した. 術前の診断では肝転移 (-) なるも, 術中迅速病理診断にて
Autor:
Tetsuya Tsukamoto, Kunihiko Nagahara, Masaharu Sudo, Tetsushi Otani, Kazuhiro Yamamoto, Kinya Koizumi
Publikováno v:
Nihon Kikan Shokudoka Gakkai Kaiho. 45:130-134
Problems in performing curative resection and immediate reconstruction for esophageal carcinoma of the cervico-thoracic segment are discussed with special reference to lymph node metastasis by analyzing 34 esophageal carcinomas of this region operate
Autor:
Kenichi Akamatsu, Tazuko Tashiro, Tomoko Matsumoto, Keiichi Kamisango, Kinya Koizumi, Kazumi Morikawa
Publikováno v:
Japanese Journal of Cancer Research : Gann
We have examined the cytotoxicity and accumulation of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato++ +)platinum(II) monohydrate (DWA2114R) in parent and cisplatin-resistant mouse P388 leukemia cells (P388 and P388/DDP), in comparison
Autor:
Tetsuro Yamashita, Hisakazu Yamagishi, Yuji Ueda, Yoshiki Itokawa, Fumihiro Taniguchi, Junichi Sakamoto, Naoki Kakihara, Eigo Otsuji, Jun Morii, Kinya Koizumi, Hideki Aragane, Satoshi Morita, Daisuke Ichikawa, Hiroshi Nishi, Masataka Shimotsuma, Kazuma Okamoto
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 13(3)
A multicenter phase II study was conducted to evaluate the efficacy and safety of a combination regimen of weekly paclitaxel plus S-1 in patients with advanced gastric cancer.Patients with previously untreated metastatic or recurrent gastric cancer r
Autor:
Hiroki Mitsui, Kazumi Morikawa, Tomoko Matsumoto, Koichi Endo, Kenichi Akamatsu, Masuo Koizumi, Kinya Koizumi
Publikováno v:
Japanese Journal of Cancer Research : Gann
The toxicities and antitumor activity of a new anticancer platinum compound, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato++ +) platinum(II) monohydrate (DWA2114R), were examined in rats by single intravenous injection in comparison w
Autor:
Junichi Sakamoto, Naoki Kakihara, Kinya Koizumi, Satoshi Morita, Hideaki Kurioka, Daisuke Ichikawa, Masahiko Nishiyama, Jun Morii, Masataka Shimotsuma, Tetsuro Yamashita, Yuji Ueda, Hisakazu Yamagishi, Kanae Nakamura, Atsushi Takenaka
Publikováno v:
Oncology. 69(3)
Objective: A phase I study of weekly intravenous paclitaxel combined with a fixed dose of S-1, a dihydropyrimidine-dehydrogenase-inhibitory oral fluoropyrimidine, was conducted for patients with advanced or recurrent gastric cancer (ARGC). Endpoints
Publikováno v:
Biologicalpharmaceutical bulletin. 17(7)
Q-35, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3- methylaminopiperidine-1-yl)-4-oxyquinoline-3-carboxylic acid, has excellent activity against gram-positive bacteria and inhibits S. aureus gyrase at concentrations more than 10-fold lower than